Ticker League

Price Target for Alto Neuroscience (ANRO)

Interactive scenarios for Alto Neuroscience (ANRO) at about $21.47. Default base case lands near $-79.88 in 5 years from 10% growth and a 20× exit P/E — roughly flat returns.

Analysis
Capital Return

No dividends or stock splits on record for this company.

Stock price

$21.47

TTM EPS

-$2.48

Net cash

$172.1M

Beta

1.25

Valuation context

How today's valuation compares to its own 5-year history.

Breakdown5Y low · median · 5Y highToday
P/S
2520.92520.92520.9
2520.9
EV/EBITDA
0.70.70.7
0.7
EPS 5Y

Scenario calculator

Enter EPS growth and exit P/E per scenario. The chart starts at the current share price (Now) and transitions the P/E from today's trailing multiple toward your Exit P/E over the horizon. Same live price and TTM EPS as the rest of the page.

Whole number from 1 to 10 years.

Annual diluted EPS

GAAP diluted EPS by fiscal year — use as context for growth assumptions above, not a forecast. Across 5 fiscal years, diluted EPS went from about $-0.36 in 2021 to about $-2.19 in 2025.

Scale: -2.50 to -0.36 EPS; horizontal line at 0. Fiscal years with no row in the database are omitted.

Alto Neuroscience (ANRO) Key Financials

Charts, filings, and peer comparison for every metric

This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.

Community price target

Where ANRO forecasters and Wall Street see the stock 12 months out. The community figure is the median saved base-case target across members, shown once at least 5 members have saved one.

Community 12-month—Appears at 5+ saved targets
Wall Street$34.60analyst consensus target
Current price$21.47latest market price

Relative valuation

How ANRO trades versus its Healthcare peers and its own history. Lower multiples are cheaper; the band marks where each multiple sits between its 5-year low (left) and high (right).

No signal
  • P/E (TTM)—
    No signal
  • EV/EBITDA—
    No signal
  • P/S (TTM)—
    No signal

Peers in the Healthcare sector

Compare ANRO against its Healthcare peers on the three core multiples. Lower is cheaper; tap a column to rank the peer set. Open any peer's price target page for its full scenario breakdown. Filtered to active common stock, excluding ETFs and funds.

About the ANRO price target calculator

The ANRO price target calculator projects a future share price by compounding trailing twelve-month earnings per share at an assumed growth rate and applying an exit P/E multiple at the end of the horizon. The stock currently trades at about $21.47.

ANRO has no usable next-year analyst EPS consensus in our dataset, so the calculator defaults to historical EPS growth for its scenarios. Without a long enough EPS history the base case defaults to 10% growth; adjust the sliders to reflect your own view.

Frequently asked questions

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Capital Return

No dividends or stock splits on record for this company.